PRFX — PRF Technologies Share News
0.000.00%
Last trade - 00:00- $2.25m
- -$5.67m
- $0.02m
Brief: Painreform Provides Business Update For The Six Months Ended June 30, 2025
PainReform Ltd expected to post a loss of $18.96 a share - Earnings Preview
PainReform Ltd expected to post a loss of $18.96 a share - Earnings Preview
PainReform Ltd expected to post a loss of $18.96 a share - Earnings Preview
Brief: Painreform Executes Definitive Agreement To Acquire Deepsolar, Marking A Unique Expansion Opportunity
PainReform Ltd expected to post a loss of $18.96 a share - Earnings Preview
PainReform Ltd expected to post a loss of $18.96 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-CNX Resources, Uber, PainReform
Brief: PainReform Provides Further Update On Phase 3 Clinical Trial Of PRF-110
PainReform falls after pain relief treatment fails late-stage trial
PainReform Ltd expected to post a loss of $18.96 a share - Earnings Preview
Brief: PainReform Announces Initial Topline Data For PRF-110 Phase 3 Clinical Trial
PainReform Ltd expected to post a loss of $4.74 a share - Earnings Preview
Brief: Painreform Announces Receipt Of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
Brief: PainReform Ltd Files For Mixed Shelf Offering Of Up To $50 Million- SEC Filing
Brief: PainReform Confirms Sutures Compatibility In Human Clinical Trials For PRF-110
Brief: PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study
PainReform Ltd expected to post a loss of $1.04 a share - Earnings Preview
Brief: Painreform Ltd On June 24, Ilan Hadar, CEO & CFO Ceased His Service To Co